HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity

Anne C Spaulding, Ryan M Seals, Matthew J Page, Amanda K Brzozowski, William Rhodes, Theodore M Hammett, Anne C Spaulding, Ryan M Seals, Matthew J Page, Amanda K Brzozowski, William Rhodes, Theodore M Hammett

Abstract

Because certain groups at high risk for HIV/AIDS (human immunodeficiency virus/acquired immunodeficiency syndrome) come together in correctional facilities, seroprevalence was high early in the epidemic. The share of the HIV/AIDS epidemic borne by inmates of and persons released from jails and prisons in the United States (US) in 1997 was estimated in a previous paper. While the number of inmates and releasees has risen, their HIV seroprevalence rates have fallen. We sought to determine if the share of HIV/AIDS borne by inmates and releasees in the US decreased between 1997 and 2006. We created a new model of population flow in and out of correctional facilities to estimate the number of persons released in 1997 and 2006. In 1997, approximately one in five of all HIV-infected Americans was among the 7.3 million who left a correctional facility that year. Nine years later, only one in seven (14%) of infected Americans was among the 9.1 million leaving, a 29.3% decline in the share. For black and Hispanic males, two demographic groups with heightened incarceration rates, recently released inmates comprise roughly one in five of those groups' total HIV-infected persons, a figure similar to the proportion borne by the correctional population as a whole in 1997. Decreasing HIV seroprevalence among those admitted to jails and prisons, prolonged survival and aging of the US population with HIV/AIDS beyond the crime-prone years, and success with discharge planning programs targeting HIV-infected prisoners could explain the declining concentration of the epidemic among correctional populations. Meanwhile, the number of persons with HIV/AIDS leaving correctional facilities remains virtually identical. Jails and prisons continue to be potent targets for public health interventions. The fluid nature of incarcerated populations ensures that effective interventions will be felt not only in correctional facilities but also in communities to which releasees return.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Hammett T, Harmon M, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health. 2002;92:1789–1794.
    1. Centers for Disease Control. HIV Testing Implementation Guidance: Correctional Settings, January 2009: 1–38. 2009. Available at: . Accessed 2 July 2009.
    1. Maruschak LM. HIV in Prisons and Jails, 1999. 2001 July. U.S. Department of Justice, Bureau of Justice Statistics, Bulletin, July 2001. NCJ 187456.
    1. Maruschak LM. HIV in prisons, 2006. U.S. Department of Justice, Bureau of Justice Statistics Bulletin, April 2008. NCJ 222179. 2008 April. Web page available at: . Accessed 15 December 2008.
    1. Sabol WJ, Minton TD, Harrison PM. Prison and jail inmates at midyear 2006. U.S. Department of Justice, Bureau of Justice Statistics, June 2007. 2007 June. NCJ 217675.Available: . Accessed 13 October 2009.
    1. Gilliard DK, Beck AJ. Prison and Jail Inmates at Midyear 1997. 1998 January. Bureau of Justice Statistics Bulletin, January 1998.NCJ 167247.
    1. Centers for Disease Control. Decrease in AIDS-related mortality in a state correctional system – New York, 1995–1998. Morb Mortal Wkly Rep. 1999;47(51):1115–1117.
    1. Beckwith CG, Atunah-Jay S, Cohen J, Macalino G, Poshkus M, et al. Feasibility and acceptability of rapid HIV testing in jail. AIDS Patient Care STDS. 2007;21:41–47.
    1. Greenwald J, Burstein G, Pincus J, Branson B. A rapid review of rapid HIV antibody tests. Curr Infect Dis Rep. 2006;8:125–131.
    1. MacGowan RJ, Margolis AD, Richardson-Moore A, Wang T, Lalota M, et al. Voluntary rapid human immunodeficiency virus (HIV) testing in jails. Sex Transm Dis. 2009;36:s9–s13.
    1. Spaulding AC, Arriola KRJ, Hammett T, Kennedy S, Tinsley M. Rapid HIV testing in rapidly released detainees: next steps. Sex Transm Dis. 2009;36:s34–s36.
    1. Martin SS, O'Connell DJ, Inciardi JA, Surratt HL, Beard RA, et al. HIV/AIDS among probationers: an assessment of risk and results from a brief intervention. J Psychoactive Drugs. 2003;35:435–443.
    1. Gardner LI, Metsch LR, Anderson-Mahoney P, Loughlin AM, del Rio C, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;19:423–431.
    1. Wolitski RJ. Relative efficacy of a multisession sexual risk-reduction intervention for young men released from prisons in 4 states. Am J Public Health. 2006;96:1854–1861.
    1. Spaulding AC, Arriola KR, Ramos KL, Hammett T, Kennedy S, et al. Enhancing linkages to HIV primary care in jail settings. J Correctional Health Care. 2007;12:93–128.
    1. Sabol WJ, Minton TD. Jail inmates at midyear 2007. U.S. Department of Justice, Bureau of Justice Statistics Bulletin, June 2008. NCJ 221945. 2008 June. Available at: . Accessed 25 June 2008.
    1. Glaze LE, Bonczar TP. Probation and Parole in the United States, 2006, U.S. Department of Justice, Bureau of Justice Statistics Bulletin, December 2007. 2007 December. NCJ 220218.
    1. Harrison PM, Beck AJ. Prisoners in 2004. U.S. Department of Justice, Bureau of Justice Statistics Bulletin, October 2005. 2005 October. NCJ 210677. Available at: . Accessed 13 October 2009.
    1. Maruschak L. HIV in Prisons and Jails, 2002. U.S. Department of Justice, Bureau of Justice Statistics Bulletin, December 2004. NCJ 205333. 2004 December. Available at: . Accessed 12 July 2006.
    1. Maruschak LM. HIV in prisons, 2005. U.S. Department of Justice, Bureau of Justice Statistics Bulletin, September 2007, Updated February 2008. NCJ 218915. 2007 September. Available at: . Accessed 2 July 2009.
    1. Centers for Disease Control and Prevention. HIV prevalence estimates–United States, 2006. Morb Mortal Wkly Rep. 2008;57:1073–1076.
    1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2006. Vol 18. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008. 2008. Also available at: . Accessed 6 November 2008.
    1. Maruschak L. Medical Problems of Jail Inmates. U.S. Department of Justice, Bureau of Justice Statistics Bulletin, November 2006. NCJ 210696. 2006 November. Available at: , last accessed 2 January 2007.
    1. Spaulding AC, Arriola KRJ, Ramos KL, Hammett T, Kennedy S, et al. Enhancing linkages to primary care in jail settings. J Correctional Health Care. 2007;13:93–128.
    1. Wohl D, Stephenson B, Scheyette A, Golin C, McKay T, et al. A randomized trial of a case management intervention to improve access to care and reduce transmission risk behavior and recidivism in HIV-infected prisoners following release: the BRIGHT study. 2006. AIDS 2006 - XVI International AIDS Conference: Abstract no. THPE0784.
    1. Wohl DA. The BRIGHT Project: Bridges to good health and treatment for HIV-infected individuals being released from prison. Infectious Diseases in Corrections Report, October–November 2007. 2007 October. Available at: . Accessed 15 December 2008.
    1. Baillargeon J, Giordano TP, Rich JD, Wu ZH, Wells K, et al. Accessing antiretroviral therapy following release from prison. JAMA. 2009;301:848–857.
    1. Kim JY, Rich J, Zeiler S, Lourie K, Vigilante K, et al. Successful community follow-up and reduced recidivism of HIV positive women prisoners. J Correctional Health Care. 1997;4:5–17.
    1. New York City Department of Health. HIV Seroprevalence Update 1999. 1999. Available at: . Accessed 28 March 2007.
    1. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States and dependent areas, by race/ethnicity, 2003–2007. HIV/AIDS Surveillance Supplemental Report 14. 2009. Available at: . Accessed 13 October 2009.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅